Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

Share Price is delayed by 15 minutes
Get Live Data
6,870.00    115.00 (1.70%)
Bid:
6,855.00
Ask:
6,860.00
Spread: 5.00 (0.073%)
Market Cap: £30.42b
CCEP Live PriceLast checked at - London Stock Exchange

Intraday Coca-cola Euro. Share Chart

Additional Listing

10 May 2019 13:30

RNS Number : 6536Y
Coca-Cola European Partners plc
10 May 2019
 

Date: 10 May 2019

Coca-Cola European Partners plc

Additional Listing

Coca-Cola European Partners plc (the 'Company') has issued and allotted 746,026 new ordinary shares of €0.01 each (the "Shares") under two employee share schemes: (1) the Coca-Cola Enterprises, Inc. 2010 Incentive Award Plan; and (2) the Coca-Cola Enterprises, Inc. Legacy Long-Term Incentive Plan.

Accordingly, an application has been made to the Financial Conduct Authority for the Shares to be admitted to listing on the Official List and to the London Stock Exchange (the "LSE") for the Shares to be admitted to trading on the Main Market of the LSE. The Shares will rank pari passu with the existing shares of the Company.

Admission of the Shares is expected on 13 May 2019.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ALSGGUAGAUPBUMU
Date   Source Headline
17th Mar 202311:55 amRNSAnnual Financial Report
14th Mar 20239:45 amRNSDirector/PDMR Shareholding
13th Mar 20234:35 pmRNSPrice Monitoring Extension
3rd Mar 20233:50 pmRNSDirector/PDMR Shareholding
1st Mar 20233:20 pmRNSTotal Voting Rights
23rd Feb 202310:30 amRNSDirector/PDMR Shareholding
16th Feb 20237:00 amRNSPreliminary Unaudited Results Q4 & FY 2022
15th Feb 20234:35 pmRNSPrice Monitoring Extension
15th Feb 202310:00 amRNSDirectorate Change
1st Feb 20233:30 pmRNSTotal Voting Rights
23rd Jan 20234:30 pmRNSDirector/PDMR Shareholding
16th Jan 20232:30 pmRNSDirector/PDMR Shareholding
3rd Jan 20232:40 pmRNSTotal Voting Rights
21st Dec 20223:45 pmRNSDirector/PDMR Shareholding
1st Dec 20223:15 pmRNSTotal Voting Rights
23rd Nov 20228:00 amRNSDirector/PDMR Shareholding
15th Nov 20225:30 pmRNSDirector/PDMR Shareholding
4th Nov 20225:20 pmRNSDirector/PDMR Shareholding
2nd Nov 20227:00 amRNSQ3, Investor Event & Interim Dividend Declaration
1st Nov 20223:45 pmRNSTotal Voting Rights
21st Oct 20223:00 pmRNSDirector/PDMR Shareholding
14th Oct 20222:30 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:30 pmRNSTotal Voting Rights
22nd Sep 20223:00 pmRNSDirector/PDMR Shareholding
20th Sep 202210:00 amRNSBlock listing Interim Review
16th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 20223:00 pmRNSDirector/PDMR Shareholding
6th Sep 20224:45 pmRNSDirector/PDMR Shareholding
1st Sep 20223:00 pmRNSTotal Voting Rights
22nd Aug 20224:00 pmRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSResults for the six months ended 1 July 2022
2nd Aug 20224:35 pmRNSPrice Monitoring Extension
1st Aug 20223:45 pmRNSTotal Voting Rights
20th Jul 20224:30 pmRNSDirector/PDMR Shareholding
14th Jul 20223:15 pmRNSDirector/PDMR Shareholding
23rd Jun 202212:30 pmRNSDirector/PDMR Shareholding
9th Jun 202212:00 pmRNSDirector/PDMR Shareholding
1st Jun 20223:10 pmRNSTotal Voting Rights
27th May 20223:30 pmRNSResult of AGM
24th May 20223:30 pmRNSDirector/PDMR Shareholding
16th May 202212:00 pmRNSLetter to Shareholders
3rd May 20222:40 pmRNSTotal Voting Rights
28th Apr 20224:41 pmRNSSecond Price Monitoring Extn
28th Apr 20224:36 pmRNSPrice Monitoring Extension
27th Apr 20227:00 amRNSQ1 2022 Trading Update
21st Apr 20225:20 pmRNSDirector/PDMR Shareholding
14th Apr 20229:00 amRNSNotice of AGM
23rd Mar 20221:50 pmRNSDirector/PDMR Shareholding
18th Mar 20222:15 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.